Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial

Taha A, Mondal A, Sandhyavenu H, Atti L, Alhajji M, Thangjui S, Shaik BF, Thyagaturu H, Caccamo M, Fonarow GC, Balla S. Outcomes of Early[...]

Nouh A, Olson D, Liang H, Koriesh A, Ali M, Bashir MMI, Mukerjee P, Man S, Fonarow GC. In-Hospital Stroke Quality and Outcomes in the[...]

Ahmed M, Hashmi TM, Shahzad M, Zia R, Ashraf H, Ahmed R, Rashid M, Greene SJ, Mentz RJ, Fudim M, Fonarow GC, Rana JS. Cardiovascular[...]